According to Fortune Business Insights the global clinical trial packaging market size was valued at USD 3.80 billion in 2023 and is projected to grow from USD 4.13 billion in 2024 to USD 8.54 billion by 2032, exhibiting a CAGR of 9.51% during the forecast period.
In 2023, North America held the largest share at about 37.9%, due to a strong pharmaceutical and biotech industry base, numerous clinical trials, and strict regulatory requirements.
Europe benefits from a mature pharmaceutical R&D ecosystem and regulatory frameworks.
Asia-Pacific shows growing potential, driven by rising clinical-trial outsourcing, expanding healthcare infrastructure, and growing pharmaceutical R&D in countries such as India and China.
Emerging regions like Latin America and the Middle East & Africa are gaining interest as clinical-trial activities expand globally, though their share remains smaller.
Get a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/clinical-trials-packaging-market-106866
Material: Plastic (most common for versatility and cost), glass (for chemical stability), metal, and paper/paperboard.
Packaging Type: Vials & ampoules dominate for biologics and injectables; bottles for oral drugs; pouches/bags for logistics and consumables.
End Users: Pharmaceutical companies, CROs, and research labs, with rising demand from outsourced trials.
Application: Used for investigational drugs, biologics, vaccines, injectables, and oral formulations; growing complexity of therapies drives need for specialized, compliant, and traceable packaging.
Rising Number of Clinical Trials & Drug Development: Growing prevalence of chronic diseases and increased focus on advanced therapeutics drive more trials, increasing packaging demand.
Growth in Biologics, Vaccines, and Personalized Medicine: Specialized packaging is required for sterile, temperature-sensitive, and tamper-evident products.
Regulatory & Compliance Requirements: Strict standards for sterilization, traceability, labeling, temperature control, and serialization boost demand for compliant packaging solutions.
Shift towards Outsourcing & CROs: Outsourced trials and packaging services increase demand for standardized, high-quality packaging solutions.
Cold-Chain and Stable Packaging for Sensitive Drugs: Biologics and vaccines require temperature-controlled containers and advanced packaging.
Adoption of Smart or Advanced Packaging Solutions: Serialization, tamper-evident features, track & trace, and advanced materials are increasingly used for multi-site, global trials.
Major companies in the market include:
Almac Group (U.K.)
Stevanato Group (U.S.)
Bilcare Ltd. (India)
Lonza Group Ltd. (Switzerland)
Piramal Pharma Solutions (U.S.)
MM Packaging GmBH (Austria)
Clinigen Limited (U.K.)
Körber AG (Germany)
PCI Pharma Services (U.S.)
Yourway (U.S.)
June 2022: Almac Group expanded its Montgomery County, Pennsylvania packaging facility to meet rising demand from next-generation clients.
April 2022: Almac Group announced a USD 65 million expansion at its North American headquarters in Souderton, including a 140% increase in the 2–8°C packaging facility and 115,000 ft² of new space, with groundbreaking in early 2023.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/clinical-trials-packaging-market-106866
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road, Baner,
Pune-411045, Maharashtra, India.
Phone:
US: +18339092966
UK: +448085020280
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com